Thank you, Madam Chair.
I welcome the witnesses who are here today to participate in this study.
My first questions are for you, Dr. Nguyen.
Canada is the only G7 country that has been reducing its investments in research and development since the early 2000s, and of course, these investments form part of its gross domestic product.
From a public health perspective, does this chronic underinvestment now limit our ability to effectively prevent antimicrobial resistance, in turn forcing hospitals, particularly in Quebec, to deal with the consequences, which are much more costly?
